Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets

Ahmed Aburima, Martin Berger, Benjamin E. J. Spurgeon, Bethany A. Webb, Katie S. Wraith, Maria Febbraio, Alastair W. Poole, Khalid M. Naseem

Blood (2021) 137 (5): 678–689.

https://doi.org/10.1182/blood.2020005382

Published: 2021

Includes: Supplemental data

Journal Articles

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications

Katherine J. Kearney, Nikoletta Pechlivani, Rhodri King, Christian Tiede, Fladia Phoenix, Ramsah Cheah, Fraser L. Macrae, Katie J. Simmons, Iain W. Manfield, Kerrie A. Smith, Benjamin E. J. Spurgeon, Khalid M. Naseem, Robert A. S. Ariens, Michael J. McPherson, Darren C. Tomlinson, Ramzi A. Ajjan

Blood (2019) 133 (11): 1233–1244.

https://doi.org/10.1182/blood-2018-06-856195

Published: 2019

Includes: Supplemental data

Journal Articles

Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade

Simbarashe Magwenzi, Casey Woodward, Katie S. Wraith, Ahmed Aburima, Zaher Raslan, Huw Jones, Catriona McNeil, Stephen Wheatcroft, Nadira Yuldasheva, Maria Febbriao, Mark Kearney, Khalid M. Naseem

Blood (2015) 125 (17): 2693–2703.

https://doi.org/10.1182/blood-2014-05-574491

Published: 2015

Includes: Multimedia, Supplemental data

Journal Articles

cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway

Ahmed Aburima, Katie S. Wraith, Zaher Raslan, Robert Law, Simbarashe Magwenzi, Khalid M. Naseem

Blood (2013) 122 (20): 3533–3545.

https://doi.org/10.1182/blood-2013-03-487850

Published: 2013

Includes: Supplemental data

Journal Articles

Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase–signaling pathways

Katie S. Wraith, Simbarashe Magwenzi, Ahmed Aburima, Yichuan Wen, David Leake, Khalid M. Naseem

Blood (2013) 122 (4): 580–589.

https://doi.org/10.1182/blood-2013-04-491688

Published: 2013

Includes: Supplemental data

Journal Articles

Platelet Ca 2+ responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca 2+ stores

C. Y. Eleanor Fung, Sarah Jones, Adwoa Ntrakwah, Khalid M. Naseem, Richard W. Farndale, Martyn P. Mahaut-Smith

Blood (2012) 119 (15): 3613–3621.

https://doi.org/10.1182/blood-2011-10-386052

Published: 2012

Journal Articles

Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade

Wayne Roberts, Simbarashe Magwenzi, Ahmed Aburima, Khalid M. Naseem

Blood (2010) 116 (20): 4297–4306.

https://doi.org/10.1182/blood-2010-01-265561

Published: 2010

Includes: Multimedia, Supplemental data

NARROW

Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications

Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade

cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway

Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase–signaling pathways

Platelet Ca 2+ responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca 2+ stores

Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade

Email alerts

ASH Publications

American Society of Hematology

Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets

Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications

Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade

cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway

Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase–signaling pathways

Platelet Ca 2+ responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca 2+ stores

Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only